Synergistic effect of interventing insulin-like growth factor-Ⅰ receptor activation combined with anti-cancer drugs in inhibiting the proliferation of hepatocellular carcinoma cells

Synergistic effect of interventing insulin-like growth factor-Ⅰ receptor activation combined with anti-cancer drugs in inhibiting the proliferation of hepatocellular carcinoma cells

ObjectiveTo investigate the intervention of gene transcription of insulin-like growth factor-Ⅰ receptor (IGF-ⅠR) and its synergistic effect with anti-cancer drugs in inhibiting the proliferation of hepatocellular carcinoma (HCC) cells. MethodsThe HBV-positive HCC PLC/PRF/5 and HBV-negative Bel-7404...

Full description

Bibliographic Details
Main Authors:	CAI Yin, YAO Min, WANG Li
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2016-08-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=7607

Similar Items

Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
by: Grabinski Nicole, et al.
Published: (2012-11-01)

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor
by: Xiao Y, et al.
Published: (2016-06-01)

MiR‐497‐5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin‐like growth factor 1
by: Guo‐shu Xu, et al.
Published: (2019-10-01)

Differential Roles of Insulin-like Growth Factor Receptor- and Insulin Receptor-mediated Signaling in the Phenotypes of Hepatocellular Carcinoma Cells
by: Ya-Wen Chen, et al.
Published: (2009-09-01)

Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway
by: Yiou Wang, et al.
Published: (2021-06-01)

Insulin-Like Growth Factor Binding Protein-2 Promotes Proliferation and Predicts Poor Prognosis in Hepatocellular Carcinoma
by: Ma Y, et al.
Published: (2020-06-01)

Role of insulin receptor substrates in the progression of hepatocellular carcinoma
by: Yoshitaka Sakurai, et al.
Published: (2017-07-01)

Targeting insulin-like growth factor axis in hepatocellular carcinoma
by: Wu Jennifer, et al.
Published: (2011-07-01)

Adenovirus-mediated Hes1 Expression Inhibits Proliferation and Migration of Hepatocellular Carcinoma Cells
by: YU Bing, et al.
Published: (2020-03-01)

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway.
by: Da-Liang Ou, et al.
Published: (2013-01-01)

The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma
by: Cheng-Chan Yu, et al.
Published: (2020-05-01)

Association of polymorphism of insulin-like growth factor genes with susceptibility to and severity of hepatocellular carcinoma
by: Yin-Hung, et al.
Published: (2009)

Leptin Receptor (LEPR) promotes proliferation, migration, and invasion and inhibits apoptosis in hepatocellular carcinoma by regulating ANXA7
by: He Huang, et al.
Published: (2021-01-01)

Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
by: Yu Q, et al.
Published: (2020-10-01)

Abnormal activation of insulin-like growth factor-I receptor in hepatocellular carcinoma and potential of IGF-IR targeted therapy
by: YAN Xiaodi
Published: (2013-06-01)

Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma
by: Jian Gao, et al.
Published: (2021-07-01)

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
by: Yafei Zhang, et al.
Published: (2012-09-01)

Gluconokinase IDNK Promotes Cell Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma
by: Wu XM, et al.
Published: (2020-02-01)

MicroRNA-130b Promotes Cell Aggressiveness by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Human Hepatocellular Carcinoma
by: Kangsheng Tu, et al.
Published: (2014-11-01)

DAX-1 Inhibits Hepatocellular Carcinoma Proliferation by Inhibiting β-Catenin Transcriptional Activity
by: Hong-Lei Jiang, et al.
Published: (2014-08-01)

Expression and Significance of Insulin Receptor Substrate 1 in Human Hepatocellular Carcinoma
by: Chun Gao, et al.
Published: (2020-01-01)

Effect of protease activated receptor 2 on proliferation and apoptosis of hepatocellular carcinoma cells
by: ZHANG Wei, et al.
Published: (2019-07-01)

The synergistic inhibition of Metformin and Emodin on androgen receptor protein and LNCaP cell proliferation
by: Hao Fang, et al.
Published: (2019)

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
by: Hsu HT, et al.
Published: (2014-08-01)

The expression of insulin-like growth factor II gene in human hepatocellular carcinoma
by: HUANG, hsiang-po, et al.
Published: (1994)

EFFECTS OF INSULIN AND INSULIN-LIKE GROWTH FACTORS ON SATELLITE CELL PROLIFERATION IN VITRO (SOMATOMEDINS, RECEPTORS).
by: Dodson, Michael Verne
Published: (1985)

Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma
by: Xiao YB, et al.
Published: (2018-06-01)

TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3
by: Shihai Liu, et al.
Published: (2021-01-01)

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
by: Yang J, et al.
Published: (2015-02-01)

Artemisia Capillaris leaves inhibit cell proliferation and induce apoptosis in hepatocellular carcinoma
by: Juyoung Kim, et al.
Published: (2018-05-01)

Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA
by: Li T, et al.
Published: (2019-04-01)

Downregulation of SUMO2 inhibits hepatocellular carcinoma cell proliferation, migration and invasion
by: Jintu Chen, et al.
Published: (2021-06-01)

Paradoxical effects of cellular senescence-inhibited gene involved in hepatocellular carcinoma migration and proliferation by ERK pathway and mesenchymal-like markers
by: Cheng Q, et al.
Published: (2019-03-01)

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma
by: Wei Tian, et al.
Published: (2012-05-01)

Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
by: Akiel M, et al.
Published: (2014-03-01)

Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting miR-199a expression
by: Shi Y, et al.
Published: (2015-08-01)

Engineering Exosome-Like Nanovesicles Derived from Asparagus cochinchinensis Can Inhibit the Proliferation of Hepatocellular Carcinoma Cells with Better Safety Profile
by: Zhang L, et al.
Published: (2021-02-01)

Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma
by: Akiko Kojima-Yuasa, et al.
Published: (2015-10-01)

Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor
by: Shuo Miao, et al.
Published: (2017-12-01)